Table 4.
Additional measurements taken during follow‐up (2014.07.22 to 2017.02.06)
| Date | FT3 pmol/L | FT4 pmol/L | TSH μIU/mL | TRAb mIU/mL | TPOAb U/mL | TgAb U/mL | Tg ng/mL | Treatment |
|---|---|---|---|---|---|---|---|---|
| Normal range | 3.5–6.5 | 11.5–22.7 | 0.55–4.78 | 0–1.58 | 0–60 | 0–60 | 1.4–78 | |
| 2013‐07‐22 | >30.8↑ | >154.8↑ | 0.013↓ | >40↑ | >1300↑ | >500↑ | 2.5 |
Methimazole 10 mg tid; Propranolol 30 mg tid |
| 2013‐08‐13 | 12.82↑ | 23.13↑ | 0.017↓ | >40↑ | >1300 | >500↑ |
Methimazole 10 mg tid; Propranolol 20 mg tid |
|
| 2013‐10‐07 | 2.15↓ | 4.09↓ | 111.531↑ | 31.81↑ | >1300↑ | >500↑ | 10.1 | Methimazole 15 mg qd |
| 2013‐11‐29 | 10.07↑ | 19.65 | 4.593 | 25.11↑ | Methimazole 10 mg qd | |||
| 2014‐02‐07 | 13.02↑ | 37.79↑ | 0.25↓ | 19.38↑ | >1300↑ | >500↑ |
Methimazole 15 mg qd Propranolol 10 mg tid |
|
| 2014‐05‐09 | 10.34↑ | 25.49↑ | 3.98 | 13.82↑ | Methimazole 10 mg qd | |||
| 2014‐07‐04 | 12.94↑ | 17.21 | 2.599 | 13.19↑ | >1300↑ | Methimazole 10 mg bid | ||
| 2014‐08‐11 | 10.46↑ | 16.52 | 12.711↑ | 9.74↑ | >1300↑ | >500↑ | Methimazole 15 mg qd | |
| 2015‐02‐09 | 9.85↑ | 24.63↑ | 4.148 | 3.99↑ | Methimazole 10 mg qd | |||
| 2015‐08‐10 | 10.15↑ | 36.53↑ | 2.989 | 4.26↑ | >1300↑ | >500↑ |
Methimazole 10 mg tid Thalidomide 50 mg bid |
|
| 2015‐10‐06 | 13.51↑ | 15.01 | 5.435↑ | 6.47↑ | >1300↑ | >500↑ |
Methimazole 10 mg bid Thalidomide 50 mg bid |
|
| 2016‐01‐26 | 7.05↑ | 5.27↓ | 69.768↑ | 2.45↑ |
Methimazole 15 mg qd Thalidomide 75 mg qn |
|||
| 2016‐05‐30 | 10.83↑ | 13.92 | 8.621↑ | 1.74↑ |
Methimazole 15 mg qd Thalidomide 50 mg qn Methylprednisolone 4 mg qd |
|||
| 2016‐08‐15 | 11.12↑ | 25.72↑ | 5.433↑ | 0.64 | Methimazole 15 mg qd | |||
| 2016‐11‐21 | 11.71↑ | 29.85↑ | 2.762 | <0.3 | Methimazole 15 mg qd | |||
| 2017‐02‐06 | 11.59↑ | 38.43↑ | 3.007 | 1.69↑ | >1300↑ | >500↑ | Methimazole 10 mg bid |